MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-26
DOI
10.1038/s41585-019-0171-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy for genitourinary tumors
- (2019) Takayuki Nakayama et al. INTERNATIONAL JOURNAL OF UROLOGY
- Nanosecond Dynamics Regulate the MIF-Induced Activity of CD74
- (2018) Georgios Pantouris et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens
- (2018) Jose Luis Perez-Gracia et al. EUROPEAN UROLOGY
- Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes
- (2018) Matthew D. Galsky et al. EUROPEAN UROLOGY
- Nivolumab for the treatment of urothelial cancers
- (2018) Min Yuen Teo et al. Expert Review of Anticancer Therapy
- The Changing Treatment Landscape for Metastatic Urothelial Carcinoma
- (2018) Thomas W. Flaig Journal of the National Comprehensive Cancer Network
- Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma
- (2018) Arlene O. Siefker-Radtke et al. JOURNAL OF UROLOGY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer
- (2018) Damiano Fantini et al. ONCOGENE
- Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients
- (2018) Pedro L. Vera et al. UROLOGY
- Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
- (2018) Carlos R. Figueiredo et al. Frontiers in Immunology
- Management of advanced prostate cancer: A systematic review of existing guidelines and recommendations
- (2018) Athanasios Dellis et al. CANCER TREATMENT REVIEWS
- ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence
- (2017) Mathieu F. Chevalier et al. JOURNAL OF CLINICAL INVESTIGATION
- Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
- (2017) Min Zou et al. Cancer Discovery
- Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity
- (2017) Stéphane Terry et al. Frontiers in Immunology
- Enhanced Mortality to Metastatic Bladder Cancer Cell Line MB49 in Vasoactive Intestinal Peptide Gene Knockout Mice
- (2017) Niely Mirsaidi et al. Frontiers in Endocrinology
- Substrate determinants of signal peptide peptidase-like 2a (SPPL2a)-mediated intramembrane proteolysis of the invariant chain CD74
- (2016) S. Huttl et al. BIOCHEMICAL JOURNAL
- Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma
- (2016) Sarah Maria Johler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia
- (2016) Amina M. Abdul-Aziz et al. CANCER RESEARCH
- D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth
- (2016) Dawei Guo et al. INTERNATIONAL JOURNAL OF CANCER
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities
- (2016) Ciaran O'Reilly et al. MEDICINAL RESEARCH REVIEWS
- CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
- (2016) H Zhang et al. ONCOGENE
- CD74 is a novel transcription regulator
- (2016) Naama Gil-Yarom et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
- (2016) Balint Otvos et al. STEM CELLS
- Nivolumab: The New Second Line Treatment for Advanced Renal-cell Carcinoma Commentary on: Nivolumab Versus Everolimus in Advanced Renal-cell Carcinoma
- (2016) Edmund C.P. Chedgy et al. UROLOGY
- Interaction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery Patients
- (2015) Christian Stoppe et al. ANTIOXIDANTS & REDOX SIGNALING
- The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma
- (2015) Beth A. Christian et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity
- (2015) Federica Finetti et al. ENDOCRINE-RELATED CANCER
- Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells
- (2015) Susann Hüttl et al. JOURNAL OF IMMUNOLOGY
- Macrophage Migration Inhibitory Factor–CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors
- (2015) Sofia Lourenco et al. JOURNAL OF IMMUNOLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic inflammation in urothelial bladder cancer
- (2015) Gabriella Nesi et al. VIRCHOWS ARCHIV
- CD74 in Kidney Disease
- (2015) Lara Valiño-Rivas et al. Frontiers in Immunology
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- HIF-α/MIF and NF-κB/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC
- (2015) Guiquan Zhu et al. NEOPLASIA
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment
- (2014) Deepa Rajasekaran et al. FASEB JOURNAL
- Cooperative Regulation of Non-Small Cell Lung Carcinoma Angiogenic Potential by Macrophage Migration Inhibitory Factor and Its Homolog, D-Dopachrome Tautomerase
- (2014) A. M. Coleman et al. JOURNAL OF IMMUNOLOGY
- MIF Promotes B Cell Chemotaxis through the Receptors CXCR4 and CD74 and ZAP-70 Signaling
- (2014) C. Klasen et al. JOURNAL OF IMMUNOLOGY
- Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
- (2014) Antonina V. Kurtova et al. NATURE
- Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses
- (2014) O. Twu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
- (2014) Koji Taniguchi et al. SEMINARS IN IMMUNOLOGY
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
- (2013) Firas Abdollah et al. Cancer Epidemiology
- Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres
- (2013) Ming-Chu Lo et al. CANCER LETTERS
- Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesis
- (2013) Shilpa Choudhary et al. CARCINOGENESIS
- Dysregulated D-dopachrome Tautomerase, a Hypoxia-inducible Factor-dependent Gene, Cooperates with Macrophage Migration Inhibitory Factor in Renal Tumorigenesis
- (2013) Vinay Pasupuleti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo
- (2013) F. Hussain et al. MOLECULAR CANCER THERAPEUTICS
- Milatuzumab-SN-38 Conjugates for the Treatment of CD74+ Cancers
- (2013) S. V. Govindan et al. MOLECULAR CANCER THERAPEUTICS
- D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
- (2012) Melanie Merk et al. CYTOKINE
- Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells
- (2012) Thomas Tawadros et al. ENDOCRINE-RELATED CANCER
- CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder
- (2012) Jung-Woo Choi et al. INTERNATIONAL JOURNAL OF UROLOGY
- Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2012) K. D. Simpson et al. JOURNAL OF IMMUNOLOGY
- Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma
- (2012) W Du et al. ONCOGENE
- Multifaceted roles of PGE2 in inflammation and cancer
- (2012) Masako Nakanishi et al. Seminars in Immunopathology
- Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma
- (2011) L. Alinari et al. BLOOD
- The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)
- (2011) M. Merk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF)
- (2010) Alissa A. Hare et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Control of p53 and NF-κB signaling by WIP1 and MIF: Role in cellular senescence and organismal aging
- (2010) Antero Salminen et al. CELLULAR SIGNALLING
- A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease
- (2010) Aaron P. Kithcart et al. FASEB JOURNAL
- Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus
- (2010) Yuriko Sanchez-Zamora et al. FASEB JOURNAL
- Macrophage Migration Inhibitory Factor Elicits an Angiogenic Phenotype in Human Ectopic Endometrial Cells and Triggers the Production of Major Angiogenic Factors via CD44, CD74, and MAPK Signaling Pathways
- (2010) Véronique Veillat et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The MIF Homologue D-Dopachrome Tautomerase Promotes COX-2 Expression through -Catenin-Dependent and -Independent Mechanisms
- (2010) D. Xin et al. MOLECULAR CANCER RESEARCH
- Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
- (2010) Y. Cho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation
- (2009) Katherine L. Meyer-Siegler et al. CANCER LETTERS
- A functional heteromeric MIF receptor formed by CD74 and CXCR4
- (2009) Verena Schwartz et al. FEBS LETTERS
- The association betweenMIF-173G>C polymorphism and prostate cancer in southern Chinese
- (2009) G.X. Ding et al. JOURNAL OF SURGICAL ONCOLOGY
- A Tautomerase-Null Macrophage Migration-Inhibitory Factor (MIF) Gene Knock-In Mouse Model Reveals That Protein Interactions and Not Enzymatic Activity Mediate MIF-Dependent Growth Regulation
- (2009) G. Fingerle-Rowson et al. MOLECULAR AND CELLULAR BIOLOGY
- Macrophage migration inhibitory factor regulatesproliferation of gastric cancer cellsvia the PI3K/Akt pathway
- (2009) Guo-Qing Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A Novel, Macrophage Migration Inhibitory Factor Suicide Substrate Inhibits Motility and Growth of Lung Cancer Cells
- (2008) M. Winner et al. CANCER RESEARCH
- Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
- (2008) Carlo Bifulco et al. CURRENT PHARMACEUTICAL DESIGN
- Critical Role of Cysteine Residue 81 of Macrophage Migration Inhibitory Factor (MIF) in MIF-induced Inhibition of p53 Activity
- (2008) Haiyoung Jung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Human Macrophage Migration Inhibitory Factor (MIF)-CD74 Antagonists via Virtual Screening
- (2008) Zoe Cournia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of the prostaglandin pathway during development of invasive bladder cancer in mice
- (2008) John A. Taylor et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started